Friday, May 27th, 2016 - RnR Market Research

Type 2 Diabetes Pipeline Market Review 2016 Report – Companies Involved (discussed) in Therapeutics Development are

Addex Therapeutics Ltd,Adocia,Advinus Therapeutics Ltd.,Aegis Therapeutics, LLC,AFFiRiS AG,Alchemia Limited,Alize Pharma SAS,AlphaMab Co., Ltd,Amarantus Bioscience Holdings, Inc.,Ambrx, Inc.,Amgen Inc.,Anchor Therapeutics, Inc.,AntriaBio, Inc.,Aphios Corporation,Araim Pharmaceuticals, Inc.,Arisaph Pharmaceuticals, Inc.,ArisGen SA,Array BioPharma Inc.,Artery Therapeutics, Inc.,Astellas Pharma Inc.,AstraZeneca Plc,AUS Bio Limited,Avaxia Biologics, Inc.,Bayer AG,Beta-Cell NV,Betagenon AB,Biocon Limited,Biodel Inc.,Biogenomics Limited,BioLingus AG,BioRestorative Therapies, Inc.,BioTherapeutics Inc.,BioTime, Inc.,Biscayne Pharmaceuticals, Inc.,Boehringer Ingelheim GmbH,Boston Therapeutics, Inc.,Braasch Biotech LLC,Bristol-Myers Squibb Company,C4X Discovery Holdings PLC,Cadila Pharmaceuticals Limited,Caldan Therapeutics Limited,Cardax Pharmaceuticals, Inc.,Carlina Technologies SAS,Carmot Therapeutics, Inc.,Catabasis Pharmaceuticals, Inc.,Celon Pharma Sp. z o.o.,Chipscreen Biosciences Ltd,Chong Kun Dang Pharmaceutical Corp.,CJ HealthCare Corp.,CohBar, Inc.,Connexios Life Sciences Pvt. Ltd.,Corium International, Inc.,CSL Limited,CureDM, Inc.,CymaBay Therapeutics, Inc.,Daewoong Pharmaceutical Co., Ltd.,Daiichi Sankyo Company, Limited,Dance Biopharm Inc.,Debiopharm International SA,Delpor, Inc.,Diabetica Limited,Diabetology (Products) Ltd,DiaMedica Inc.,Diasome Pharmaceuticals, Inc.,DiscoveryBiomed, Inc.,Eisai Co., Ltd.,Elcelyx Therapeutics, Inc.,Eli Lilly and Company,enGene, Inc,Enzo Biochem, Inc.,Epichem Pty Ltd,Esperion Therapeutics, Inc.,Eternygen GmbH,Euroscreen S.A.,Evotec AG,F. Hoffmann-La Roche Ltd.,FibroStatin SL,Flamel Technologies S.A.,Foresee Pharmaceuticals, LLC,Generex Biotechnology Corporation,Genfit SA,Genovate Biotechnology Co., LTD.,Gero Corp,Geropharm,GlaxoSmithKline Plc,Glide Pharmaceutical Technologies Limited,Glucox Biotech AB,GW Pharmaceuticals Plc,Hadasit Medical Research Services & Development Ltd,Halozyme Therapeutics, Inc.,HanAll Biopharma Co., Ltd.,Handok Inc.,Hanmi Pharmaceuticals, Co. Ltd.,Heptares Therapeutics Limited,Hua Medicine Ltd.,Hyundai Pharmaceutical Co., Ltd.,Immuron Limited,Innopharmax Inc.,Intarcia Therapeutics, Inc.,Integral Molecular, Inc.,IntelliCell BioSciences Inc.,Intercept Pharmaceuticals, Inc.,Intrexon Corporation,Ionis Pharmaceuticals, Inc.,IPCA Laboratories Limited,Islet Sciences, Inc.,iTherX, Inc.,Japan Tobacco Inc.,Jeil Pharmaceutical Co., Ltd.,Jenrin Discovery, Inc.,JHL Biotech, Inc.,Jiangsu Hengrui Medicine Co., Ltd.,Johnson & Johnson,Kadimastem Ltd.,Kadmon Corporation, LLC,Kareus Therapeutics, SA,Kissei Pharmaceutical Co., Ltd.,Lexicon Pharmaceuticals, Inc.,LG Life Science LTD.,Ligand Pharmaceuticals, Inc.,Lonestar Heart, Inc.,Longevity Biotech, Inc,Magnus Life Science,Medesis Pharma S.A.,Medestea Research & Production S.p.A.,MedImmune, LLC,Mellitech SAS,Merck & Co., Inc.,Mesoblast Limited,Metabolic Solutions Development Company, LLC,Metabolys SAS,MI.TO. Technology S.r.L.,MicroBiome Therapeutics LLC,MidaSol Therapeutics LP,Mitsubishi Tanabe Pharma Corporation,Naia Limited,Neurimmune Holding AG,Neurocrine Biosciences, Inc.,NGM Biopharmaceuticals, Inc.,Nimbus Therapeutics, LLC,NOD Pharmaceuticals, Inc.,Nordic Bioscience A/S,Novartis AG,NovaTarg Therapeutics, Inc,Novo Nordisk A/S,Noxxon Pharma AG,Omeros Corporation,OPKO Health, Inc.,Oramed Pharmaceuticals, Inc.,Orbis Biosciences, Inc.,Panacea Biotec Limited,Paras Biopharmaceuticals Finland Oy,Peptron, Inc.,Pfizer Inc.,PharmaIN Corporation,PhaseBio Pharmaceuticals, Inc.,Pivot Pharmaceuticals Inc,Poxel SA,Progen Pharmaceuticals Limited,Prometheon Pharma, LLC,ProMetic Life Sciences Inc.,Prothena Corporation Plc,Purzer Pharmaceutical Co., Ltd.,Reata Pharmaceuticals, Inc.,Red Glead Discovery AB,RegenMedTX, LLC,reMYND NV,Rhizen Pharmaceuticals S.A.,Rhythm Pharmaceuticals, Inc.,Saniona AB,Sanofi,Sanwa Kagaku Kenkyusho Co., Ltd.,SATT Conectus Alsace SAS,SBI Pharmaceuticals Co., Ltd.,Seres Therapeutics, Inc.,Serodus ASA,Serometrix, LLC,Sevion Therapeutics, Inc.,Shanghai Fosun Pharmaceutical (Group) Co., Ltd.,Shanghai Pharmaceutical Co., Ltd.,Shantani Proteome Analytics Pvt. Ltd.,Shionogi & Co., Ltd.,Sihuan Pharmaceutical Holdings Group Ltd.,Sirona Biochem Corp,SJT Molecular Research, S.L.,SK Chemicals Co., Ltd.,Sprint Bioscience AB,Starpharma Holdings Limited,Stelic Institute & Co., Inc.,Strongbridge Biopharma plc,Sumitomo Dainippon Pharma Co., Ltd.,Taisho Pharmaceutical Holdings Co., Ltd.,Takeda Pharmaceutical Company Limited,Teijin Pharma Limited,Theracos, Inc.,Therapix Biosciences Ltd,Thermalin Diabetes, LLC,Thetis Pharmaceuticals LLC,Toray Industries, Inc.,Torrent Pharmaceuticals Limited,Transgene Biotek Limited,TWi Pharmaceuticals, Inc.,Uni-Bio Science Group Ltd.,Valeant Pharmaceuticals International, Inc.,Vicore Pharma AB,Viking Therapeutics, Inc.,Virobay Inc.,Vivus, Inc.,vTv Therapeutics LLC,Vybion, Inc.,XBiotech USA, Inc.,Xenetic Biosciences (UK) Limited,Xizang Haisco Pharmaceutical Group Co., Ltd.,XL-protein GmbH,XOMA Corporation,Yuhan Corporation,Yungjin Pharm. Co., Ltd.,Zafgen Inc.,Zealand Pharma A/S,Zensun (Shanghai) Sci & Tech Co., Ltd.,Zydus Cadila Healthcare Limited

To Inquire more about this Market Research Report – http://www.rnrmarketresearch.com/contacts/inquire-before-buying?rname=582454

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope-

  • The report provides a snapshot of the global therapeutic landscape of Type 2 Diabetes
  • The report reviews pipeline therapeutics for Type 2 Diabetes by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved Type 2 Diabetes therapeutics and enlists all their major and minor projects
  • The report assesses Type 2 Diabetes therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news related to pipeline therapeutics for Type 2 Diabetes

To avail DISCOUNT on this report – http://www.rnrmarketresearch.com/contacts/discount?rname=582454

Reasons to buy –

  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Type 2 Diabetes
  • Identify potential new clients or partners in the target demographic
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Type 2 Diabetes pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic porfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

File Library

Contact Profile

RnR Market Research


About Us:  

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us: 

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed


Ritesh Tiwari
P: + 1 888 391 5441
W: www.rnrmarketresearch.com/

Keywords

Type 2 Diabetes, Type 2 Diabetes Pipeline, Type 2 Diabetes Market, Type 2 Diabetes Research, Type 2 Diabetes Therapeutics

Categories

Newsrooms

Sharing

More Formats